Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Merck
Teva
Express Scripts
US Department of Justice
Argus Health
Queensland Health
Julphar

Generated: April 22, 2018

DrugPatentWatch Database Preview

MIVACRON Drug Profile

« Back to Dashboard

Which patents cover Mivacron, and what generic alternatives are available?

Mivacron is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in MIVACRON is mivacurium chloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mivacurium chloride profile page.
Drug patent expirations by year for MIVACRON
Synonyms for MIVACRON
(1R,1'R)-2,2'-((((E)-oct-4-enedioyl)bis(oxy))bis(propane-3,1-diyl))bis(6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-2-ium) chloride
(1R)-2-(3-{[(4E)-8-{3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl]propoxy}-8-oxooct-4-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,
(R)-1,2,3,4-Tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride, (E)-4-octenedioate (2:1)
[R-[R*,R*-(E)]]2,2'-(1,8-Dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl)bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)isoquinolinium] dichloride
106791-40-6
106861-44-3
133814-19-4
2,2'-[(1,8-Dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl)]bis[1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]isoquinolinium
791M406
AC1NQXXZ
AC1NQXZZ
AKOS025311198
AN-33846
AN-7609
bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate
bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate dichloride
BW B109OU dichloride
BW-B1090U
BW-B109OU
BW-B109OU DICHLORIDE
BWB109OU
C07550
C58H80Cl2N2O14
C58H80N2O14
CAS-106861-44-3
CAS-133814-19-4
CHEBI:6958
CHEBI:6959
CHEMBL1182833
CHEMBL984
Chlorure de mivacurium
Chlorure de mivacurium [French]
Cloruro de mivacurio
Cloruro de mivacurio [Spanish]
D00763
D0OB2M
DB01226
DSSTox_CID_26649
DSSTox_CID_28308
DSSTox_GSID_46649
DSSTox_GSID_48333
DSSTox_RID_81794
DSSTox_RID_82751
DTXSID5046649
DTXSID6048333
GTPL7243
Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-, (1R-(1R*(E(1'R*))))-
Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl)-, dichloride, (R-(R*,R*-(E)))-
LP066516
LS-172022
Mivacron (TN)
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER
Mivacurii chloridum
Mivacurii chloridum [Latin]
Mivacurium
MIVACURIUM CHLORIDE
Mivacurium chloride (USAN/INN)
Mivacurium chloride [USAN:INN:BAN]
Mivacurium chloride(USAN/INN)
MolPort-023-220-239
NCGC00167469-01
NCGC00183094-01
SCHEMBL10014476
SCHEMBL10666657
SCHEMBL10666872
SCHEMBL41232
Tox21_112473
Tox21_112909

US Patents and Regulatory Information for MIVACRON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie MIVACRON mivacurium chloride SOLUTION;INTRAVENOUS 020098-001 Jan 22, 1992 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER mivacurium chloride INJECTABLE;INJECTION 020098-002 Jan 22, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie MIVACRON mivacurium chloride SOLUTION;INTRAVENOUS 020098-004 Jan 22, 1992 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Abbvie MIVACRON mivacurium chloride SOLUTION;INTRAVENOUS 020098-005 Jan 22, 1992 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Citi
Dow
Medtronic
Teva
McKesson
Queensland Health
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.